Most people know only two things about the appendix: You don’t need it – and if it bursts, you need surgery fast. That basic story traces back at least to Charles Darwin, the English naturalist who ...
ENHERTU Granted Priority Review in the U.S. as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer ...
AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application (sBLA) for ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been accepted and granted Priority Review in the US for the ...